DexCom Inc (NAS:DXCM)
$ 80.24 0.7 (0.88%) Market Cap: 31.07 Bil Enterprise Value: 31.36 Bil PE Ratio: 47.63 PB Ratio: 15.70 GF Score: 79/100

DexCom Inc at William Blair Growth Stock Conference Transcript

Jun 09, 2020 / 05:40PM GMT
Release Date Price: $95.13 (+3.22%)
Malgorzata Maria Kaczor
William Blair & Company L.L.C., Research Division - Research Analyst

Hey, good morning, everyone. Thanks for joining us. My name is Margaret Kaczor, and I am the research analyst here at William Blair & Company who covers DexCom.

Now before we begin, I am required to inform you that I personally own shares of DexCom. But beyond that, you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.

I'll do a short introduction then we'll kind of drive over to Q&A. But DexCom has been one of the top-performing stocks on our coverage universe over the last -- now 3 years probably. And despite the years of strong growth, sales continue to accelerate in spite of competition, pricing and tough comps. The impact of the pandemic is a little uncertain. We'll talk about that. But ultimately, as we look at the stock, the story from here is, where does diabetes management go over the next 3 years? Over the next 5 years? How important is innovation and access and data? And from our perspective, DexCom has been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot